Conmed (CNMD) Tops Q3 EPS by 6c; Raises Outlook
Tweet Send to a Friend
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.62, $0.06 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
